Proteomics

Dataset Information

0

A proximity labeling method for protein-protein interactions on cell membrane


ABSTRACT: We introduce antigen-antibody proximity labeling (AAPL), a novel method to map the antigen interaction sites as well as interactors of antibody-targeted proteins. As a proof of concept, AAPL was demonstrated using sodium/potassium transporting ATPase (ATP1A1) and epidermal growth factor receptor 2 (ERBB2)-specific antibodies that were modified with an Fe(III) catalytic probe. Once bound to their target proteins, Fe(III)-induced catalytic oxidation occurred in proximity of the antigen’s epitope. Oxidative proteomic analysis was then used to determine the degree of oxidation, the site of oxidation within the targeted antigen, and the interacting proteins that were in close proximity to the targeted antigen. An AAPL score was generated for each protein yielding the specificity of the oxidation and proximity of the interacting protein to the target antigen. As a final demonstration of its utility, the AAPL approach was applied to map the interactors of liver-intestine-cadherin (CDH17) in colon cancer cells.

INSTRUMENT(S): Orbitrap Fusion Lumos

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Qiongyu Li  

LAB HEAD: Carlito B Lebrilla

PROVIDER: PXD033466 | Pride | 2022-08-12

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
Caco2_A1.mzid.gz Mzid
Caco2_A1.raw Raw
Caco2_A2.mzid.gz Mzid
Caco2_A2.raw Raw
Caco2_C1.mzid.gz Mzid
Items per page:
1 - 5 of 81
altmetric image

Publications

A proximity labeling method for protein-protein interactions on cell membrane.

Li Qiongyu Q   Xie Yixuan Y   Rice Rachel R   Maverakis Emanual E   Lebrilla Carlito B CB  

Chemical science 20220430 20


Antibodies targeting specific antigens are widely utilized in biological research to investigate protein interactions or to quantify target antigens. Here, we introduce antigen-antibody proximity labeling (AAPL), a novel method to map the antigen interaction sites as well as interactors of antibody-targeted proteins. As a proof of concept, AAPL was demonstrated using sodium/potassium transporting ATPase (ATP1A1) and epidermal growth factor receptor 2 (ERBB2)-specific antibodies that were modifie  ...[more]

Similar Datasets

2024-02-01 | GSE242759 | GEO
2024-02-01 | GSE242758 | GEO
2008-05-22 | GSE8338 | GEO
2008-05-21 | E-GEOD-8338 | biostudies-arrayexpress
2011-07-20 | GSE30798 | GEO
2011-07-20 | GSE30799 | GEO
2011-07-20 | GSE30801 | GEO
2011-07-20 | GSE28549 | GEO
2015-07-30 | MODEL1507180000 | BioModels
2008-09-05 | GSE8983 | GEO